MétaCan
Menu
Back to cohort
Record W4212979581 · doi:10.1093/neuonc/nov061.111

MB-35 * VERY ENCOURAGING LONG-TERM SURVIVAL AND NEUROCOGNITIVE OUTCOME OF YOUNG CHILDREN TREATED FOR MEDULLOBLASTOMA WITH SEQUENTIAL HIGH DOSE CHEMOTHERAPY

2015· article· en· W4212979581 on OpenAlexaff
Lucie Lafay‐Cousin, Susan Chi, Amy Smith, Elizabeth Wells, Jennifer R. Madden, Ashley Margol, Vijay Ramaswamy, Emily Owen, Douglas Strother, Girish Dhall, Nicholas K. Foreman, Roger J. Packer, Éric Bouffet

Bibliographic record

VenueNeuro-Oncology · 2015
Typearticle
Languageen
FieldMedicine
TopicGlioma Diagnosis and Treatment
Canadian institutionsHospital for Sick ChildrenAlberta Children's Hospital
Fundersnot available
KeywordsMedulloblastomaNeurocognitiveTerm (time)ChemotherapyOutcome (game theory)MedicinePediatricsOncologyInternal medicineCognitionMathematicsPhysicsPsychiatryPathology

Abstract

fetched live from OpenAlex

BACKGROUND: High dose chemotherapy strategies were developed to avoid craniospinal irradiation and prevent unacceptable neurotoxicity in young children. However, long-term outcome, including neurocognitive outcome of this approach has not been widely described. METHODS: This retrospective study collected data from 7 institutions, on young children with medulloblastoma treated with high-dose Carboplatin, Thiotepa according to the protocol CCG99703 between 1998-2012. Data on pathology, molecular subgrouping, chemotherapeutic, radiation, ototoxicity, neurocognitive evaluations and survival were collected. RESULTS: The cohort included 53(30 males) patients diagnosed at a median age of 24 months (2.9-63.2). Twenty (37.7%) were metastatic at diagnosis and 35(66%) underwent gross total resection(GTR). Seventeen patients (32.1%) had nodular desmoplastic (ND) histology. SHH subgroup accounted for 55.8% of the 43 patients tested (including 8/24 classic medulloblastoma). Seventeen (32.1%) patients received radiation, including 9 (16.9%) in an adjuvant setting. The 5 y PFS and OS for the entire cohort was 69.6% (±6.9%) and 76.1%(±6.5) respectively. The 5 y PFS for the patients with classic MB treated without adjuvant RT was 58.5%(±11.5%). GTR, ND histology, SHH subgroup, and continuous complete remission(CCR) were significantly associated with better PFS, but only the SHH subgroup, and CCR post consolidation remained significant for better OS, whereas macroscopic metastasis(M2/3) was associated with worst survival. Adjuvant radiation was not associated with improved outcome. Fifteen(45.5% of tested patients) patients had severe ototoxicity(≥ Chan 2b) including 13 who required hearing support. Neurocognitive assessments were available in 24 surviving patients (57%). Mean FSIQ for the cohort was 91.6 (52-119). CONCLUSION: Young children with medulloblastoma treated with this strategy have a very encouraging OS(76.1%) with < 20% patients who received adjuvant radiation. For classic medulloblastoma patients, this strategy shows an encouraging PFS of 58% without adjuvant radiation. Although ototoxicity is significant, neurocognitive profile of the survivors appears to be within the normal range.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.005

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.031
GPT teacher head0.312
Teacher spread0.281 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2015
Admission routes1
Has abstractyes

Explore more

Same venueNeuro-OncologySame topicGlioma Diagnosis and TreatmentFrench-language works237,207